FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366365220> ?p ?o ?g. }

• W4366365220 abstract "Abstract Disease modifying therapies aiming to preserve β-cell function in patients with adult-onset autoimmune type 1 diabetes are lacking. Here, we conducted a multi-centre, randomized, controlled trial to assess the β-cell preservation effects of saxagliptin alone and saxagliptin combined with vitamin D as adjunctive therapies in adult-onset autoimmune type 1 diabetes. In this 3-arm trial, 301 participants were randomly assigned to a 24-month course of the conventional therapy (metformin with or without insulin) or adjunctive saxagliptin or adjunctive saxagliptin plus vitamin D to the conventional therapy. The primary endpoint was the change from baseline to 24 months in the fasting C-peptide. The secondary endpoints included the area under the concentration-time curve (AUC) for C-peptide level in a 2-h mixed-meal tolerance test, glycemic control, total daily insulin use and safety, respectively. The primary endpoint was not achieved in saxagliptin plus vitamin D group ( P = 0.18) and saxagliptin group ( P = 0.26). However, compared with the conventional therapy, 2-h C-peptide AUC from 24 months to baseline decreased less with saxagliptin plus vitamin D (-276 pmol/L vs. -419 pmol/L; P = 0.01), and not to the same degree with saxagliptin alone (-314 pmol/L; P = 0.14). Notably, for participants with higher glutamic acid decarboxylase antibody (GADA) levels, the decline of β-cell function was much lower in saxagliptin plus vitamin D group than in the conventional therapy group ( P = 0.001). Insulin dose was significantly reduced in both active treatment groups than in the conventional therapy group despite all groups having similar glycemic control. In conclusion, the combination of saxagliptin and vitamin D preserves pancreatic β-cell function in adult-onset autoimmune type 1 diabetes, an effect especially efficacious in individuals with higher GADA levels. Our results provide evidence for a novel adjunct to insulin and metformin as potential initial treatment for adult-onset type 1 diabetes. (ClinicalTrials.gov identifier: NCT02407899)." @default.
• W4366365220 created "2023-04-21" @default.
• W4366365220 creator A5004185729 @default.
• W4366365220 creator A5005429262 @default.
• W4366365220 creator A5011703930 @default.
• W4366365220 creator A5024340003 @default.
• W4366365220 creator A5027598109 @default.
• W4366365220 creator A5040985281 @default.
• W4366365220 creator A5049407947 @default.
• W4366365220 creator A5051839885 @default.
• W4366365220 creator A5052174052 @default.
• W4366365220 creator A5072196735 @default.
• W4366365220 creator A5074571072 @default.
• W4366365220 creator A5076079188 @default.
• W4366365220 creator A5077323251 @default.
• W4366365220 creator A5079650987 @default.
• W4366365220 creator A5079738340 @default.
• W4366365220 date "2023-04-20" @default.
• W4366365220 modified "2023-09-26" @default.
• W4366365220 title "Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial" @default.
• W4366365220 cites W1888317895 @default.
• W4366365220 cites W1917326214 @default.
• W4366365220 cites W1972272954 @default.
• W4366365220 cites W1978466632 @default.
• W4366365220 cites W1978975080 @default.
• W4366365220 cites W1991909333 @default.
• W4366365220 cites W2001834753 @default.
• W4366365220 cites W2008870899 @default.
• W4366365220 cites W2041637201 @default.
• W4366365220 cites W2051774987 @default.
• W4366365220 cites W2067644596 @default.
• W4366365220 cites W2084797116 @default.
• W4366365220 cites W2123864694 @default.
• W4366365220 cites W2166848153 @default.
• W4366365220 cites W2171457872 @default.
• W4366365220 cites W2416473596 @default.
• W4366365220 cites W2790501791 @default.
• W4366365220 cites W2801592884 @default.
• W4366365220 cites W2883718598 @default.
• W4366365220 cites W2899413932 @default.
• W4366365220 cites W2946960604 @default.
• W4366365220 cites W2972530371 @default.
• W4366365220 cites W2973119673 @default.
• W4366365220 cites W2991077754 @default.
• W4366365220 cites W3005666168 @default.
• W4366365220 cites W3013558293 @default.
• W4366365220 cites W3016370459 @default.
• W4366365220 cites W3080476633 @default.
• W4366365220 cites W3134851073 @default.
• W4366365220 cites W3186618984 @default.
• W4366365220 cites W3192200717 @default.
• W4366365220 cites W3204080639 @default.
• W4366365220 cites W3205932037 @default.
• W4366365220 cites W3209121959 @default.
• W4366365220 cites W4225388269 @default.
• W4366365220 cites W4235093819 @default.
• W4366365220 doi "https://doi.org/10.1038/s41392-023-01369-9" @default.
• W4366365220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37076476" @default.
• W4366365220 hasPublicationYear "2023" @default.
• W4366365220 type Work @default.
• W4366365220 citedByCount "0" @default.
• W4366365220 crossrefType "journal-article" @default.
• W4366365220 hasAuthorship W4366365220A5004185729 @default.
• W4366365220 hasAuthorship W4366365220A5005429262 @default.
• W4366365220 hasAuthorship W4366365220A5011703930 @default.
• W4366365220 hasAuthorship W4366365220A5024340003 @default.
• W4366365220 hasAuthorship W4366365220A5027598109 @default.
• W4366365220 hasAuthorship W4366365220A5040985281 @default.
• W4366365220 hasAuthorship W4366365220A5049407947 @default.
• W4366365220 hasAuthorship W4366365220A5051839885 @default.
• W4366365220 hasAuthorship W4366365220A5052174052 @default.
• W4366365220 hasAuthorship W4366365220A5072196735 @default.
• W4366365220 hasAuthorship W4366365220A5074571072 @default.
• W4366365220 hasAuthorship W4366365220A5076079188 @default.
• W4366365220 hasAuthorship W4366365220A5077323251 @default.
• W4366365220 hasAuthorship W4366365220A5079650987 @default.
• W4366365220 hasAuthorship W4366365220A5079738340 @default.
• W4366365220 hasBestOaLocation W43663652201 @default.
• W4366365220 hasConcept C124490489 @default.
• W4366365220 hasConcept C126322002 @default.
• W4366365220 hasConcept C134018914 @default.
• W4366365220 hasConcept C168563851 @default.
• W4366365220 hasConcept C203092338 @default.
• W4366365220 hasConcept C2777180221 @default.
• W4366365220 hasConcept C2779284873 @default.
• W4366365220 hasConcept C2779306644 @default.
• W4366365220 hasConcept C2780282729 @default.
• W4366365220 hasConcept C2780323712 @default.
• W4366365220 hasConcept C2780473172 @default.
• W4366365220 hasConcept C555293320 @default.
• W4366365220 hasConcept C71924100 @default.
• W4366365220 hasConceptScore W4366365220C124490489 @default.
• W4366365220 hasConceptScore W4366365220C126322002 @default.
• W4366365220 hasConceptScore W4366365220C134018914 @default.
• W4366365220 hasConceptScore W4366365220C168563851 @default.
• W4366365220 hasConceptScore W4366365220C203092338 @default.
• W4366365220 hasConceptScore W4366365220C2777180221 @default.
• W4366365220 hasConceptScore W4366365220C2779284873 @default.
• W4366365220 hasConceptScore W4366365220C2779306644 @default.
• W4366365220 hasConceptScore W4366365220C2780282729 @default.

• next